Gapping up on strong earnings/guidance:

FCEL +4.3%, MIND +5.1%... Other news: DRL +11.7% (Board authorizes discussions with FBOP to review previously reported proposal), ONCY +10.1% (announces positive clinical data from U.S. phase 1 Reolysin trial), FMP +9.8% (announces exploration of strategic alternatives to enhance shareholder value), QGEN +7.5% (upgraded at WestLB, following yesterday's ~10% sell-off after announcing DIGE acquisition), RACK +7.0% (follow-through momentum following yesterday's +5% move, after Jon Najarian discusses co as takeover candidate on CNBC this morning), IDMI +6.8% (presents interim Phase 2 data from EP-2101 lung cancer vaccine clinical trial), RAD +3.1% (positive Cramer mention), AV +2.6% (to be acquired by Silver Lake and TPG Capital for $17.50